SGP — SPYGLASS PHARMA INC

As of Q2 2026, 18 SEC-registered investment managers reported holding SGP (SPYGLASS PHARMA INC) in their latest 13F filings, with a combined reported value of $57.97M across 3.29M shares. That is +71.8% by share count (+1.38M shares) versus the previous quarter, while reported value moved +84.2%. Ownership is concentrated: the five largest holders account for 89.9% of reported value and the top ten for 98.2%.

Compared with the prior quarter, 7 opened new positions, 8 added to existing stakes, 3 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

SGP is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.